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Background: The effect of seizure suppression by acupuncture of Feng-Chi (GB20) acupoints has been
documented in the ancient Chinese literature, Lingshu Jing (Classic of the Miraculous Pivot), however, there is a lack
of scientific evidence to prove it. This current study was designed to elucidate the effect of electroacupuncture (EA)
stimulation of bilateral Feng-Chi (GB20) acupoints on the epileptic activity by employing an animal model of focal
epilepsy.
Methods: Administration of pilocarpine into the left central nucleus of amygdala (CeA) induced the focal epilepsy
in rats. Rats received a 30-min 100 Hz EA stimulation of bilateral Feng-Chi acupoints per day, beginning at 30
minutes before the dark period and performing in three consecutive days. The broad-spectrum opioid receptor
antagonist (naloxone), μ-receptor antagonist (naloxonazine), δ-receptor antagonist (naltrindole) and κ-receptor
antagonist (nor-binaltorphimine) were administered directly into the CeA to elucidate the involvement of CeA
opioid receptors in the EA effect.
Results: High-frequency (100 Hz) EA stimulation of bilateral Feng-Chi acupoints did not suppress the
pilocarpine-induced epileptiform electroencephalograms (EEGs), whereas it further increased the duration of
epileptiform EEGs. We also observed that epilepsy occurred while 100 Hz EA stimulation of Feng-Chi acupoints was
delivered into naïve rats. EA-induced augmentation of epileptic activity was blocked by microinjection of naloxone,
μ- (naloxonazine), κ- (nor-binaltorphimine) or δ-receptor antagonists (natrindole) into the CeA, suggesting that
activation of opioid receptors in the CeA mediates EA-exacerbated epilepsy.
Conclusions: The present study suggests that high-frequency (100 Hz) EA stimulation of bilateral Feng-Chi acupoints has
no effect to protect against pilocarpine-induced focal epilepsy; in contrast, EA further exacerbated focal epilepsy induced
by pilocarpine. Opioid receptors in the CeA mediated EA-induced exacerbation of focal epilepsy.
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Acupuncture has been used as an alternative medicine
to effectively treat patients with chronic pain [1] (e.g.,
migraines, tension-type headache and peripheral joint
osteoarthritis [2]) by manipulating thin needles that have
been inserted into the acupoints. Electroacupuncture* Correspondence: ctlin@ntu.edu.tw; fchang@ntu.edu.tw
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reproduction in any medium, provided the or(EA) is a modified form of acupuncture, which consists
of passing an electrical current through needles into the
acupoints and controls the acupuncture dose by modify-
ing the frequency and intensity of stimulating currents.
Acupuncture had been documented in some Chinese
literatures indicating the therapeutic effect in epilepsy,
insomnia, and other neurological diseases, in addition to
its indication in pain relief. For example, the effect of
epileptic suppression by acupuncture of Feng-Chi (GB20)
acupoints has been documented in the Lingshu Jing
(Classic of the Miraculous Pivot). However, there is a
lack of scientific evidence to elucidate its underlyinghis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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one of the most common and devastating neurological
disorders. About seventy percent of patients with epilepsy
can be well-controlled with currently available anti-
epileptic drugs (AEDs), but seizures still persist in 30% of
epilepsy patients who do not respond to any of two to
three first-line AEDs despite administration of the
carefully optimized drug treatment [3]. Alternative therap-
ies, such as vagus nerve stimulation [4,5], deep brain
stimulation (DBS) [6] and acupuncture [7,8], have been
considered for treating refractory epilepsy. Several reports
demonstrate that acupuncture may suppress seizure
activity through the activation of vagus nerve, which sub-
sequently activates the nucleus of tractus solitarius (NTS)
[7,8]. Our previous results demonstrate that EA stimula-
tion of bilateral Anmian (EX17) acupoints enhances sleep
through the activation of opioid receptors in the NTS
[9,10]. Feng-Chi acupoint is anatomically close to the
Anmain acupoint. It has been shown that amygdala
receives the afferent projection from the NTS [11,12].
Altering the NTS activity changes dynorphin gene expres-
sion in the amygdala [13]. Therefore, stimulation of Feng-
Chi acupoints may activate vagus nerve and subsequently
modify the opioid receptors in the amygdala to achieve
its effect in suppressing focal epilepsy. This study was
designed to elucidate the effect of high-frequency
(100 Hz) EA stimulation of Feng-Chi acupoints in an
animal model of focal epilepsy by administering pilocar-
pine into the left central nucleus of amygdala (CeA).
Discovery of endogenous opioid peptides, including β-
endorphin, dynorphin, enkephalin and endomorphin, in
the central nervous system (CNS) reveals the mysterious
actions of acupuncture, especially in its analgesic effect. It
had first been demonstrated that the acupuncture-induced
analgesic effect could be blocked by a broad-spectrum opi-
oid receptor antagonist naloxone in both humans and mice
[14,15], implicating the role of endogenous opioid peptides.
Chang and Pomeranz had revealed that relatively low doses
of naloxone only block the analgesic effect induced by low-
frequency (4 Hz) of electroacupuncture (EA) stimulation,
but not the consequence induced by high-frequency
(200 Hz) of EA [16], suggesting that the low-frequency, ra-
ther than the high-frequency, of EA increases the release of
endogenous opioids. Nevertheless, Han and his colleagues
have further shown that the increase of endogenous opioids
mediates the analgesic effects induced by both the low-
frequency and high-frequency EA stimuli by employing dis-
tinct opioid receptor subtype-specific antagonists [17,18].
While μ- and δ-opioid receptors in the spinal cord are
dominant in the low-frequency EA-induced analgesia,
κ-opioid receptors contribute to the high-frequency EA ef-
fects [17,18]. Radioimmunoassay of spinal perfusates from
rats receiving various frequencies of EA stimulations fur-
ther indicates that 2 Hz EA enhances enkephalin (a mixedμ- and δ-opioid receptor agonist) immunoreactivity (IR),
but not the dynorphin (κ- opioid receptor agonist) IR. In
contrast, 100 Hz EA increases dynorphin IR rather than
enkephalin IR [19]. However, whether EA of bilateral Feng-
Chi acupoints alters the activity of opioid receptors in the
CeA and subsequently changes the epileptic activity in the
model of focal epilepsy is not determined. Our current
study further elucidated the involvement of CeA opioid re-
ceptors in the alteration of epileptic activity induced by




Stock solutions of a broad-spectrum opioid antagonist
(naloxone hydrochloride (Tocris, Bristol, UK)), a μ-recep-
tor antagonist (naloxonazine dihydrochloride (Tocris)), a
δ-receptor antagonist (naltrindole hydrochloride (Tocris))
and a κ-receptor antagonist (nor-binaltorphimine dihy-
drochloride (Tocris)) were dissolved in pyrogen-free saline
(PFS). Pilocarpine (1 mg/1 μl) was also dissolved in PFS.
The stock solutions were stored at 4°C until use. Our pre-
vious results and others have indicated that the appropriate
microinjection dosage for naloxonazine, naltrindole and
nor-binaltorphimine to selectively block μ-, δ- and κ-opioid
receptors, without interaction with other opioid receptor
subtypes, is within 20 μg [9,10,20,21]. In current study,
naloxone, naloxonazine, naltrindole and nor-binaltorphi-
mine were microinjected at the dose of 10 μg/μl, which
efficiently exhibits their effect of pharmacological blockade
according to our previous studies [9,10]. The total volume
used for each microinjection was 1 μl.
Animals
Male Sprague-Dawley rats (250 - 300 g; National Labora-
tory Animal Breeding and Research Center, Taiwan) were
used in this study. Rats were anesthetized by intraperito-
neal injection with 50 mg/kg Zoletil® (Virbac, Carros,
France). Most of rats (groups 2-8, see the experimental
protocol) were surgically implanted with three electro-
encephalogram (EEG) screw electrodes as previously
described [22] and a microinjection guide cannulae di-
rected into the left CeA (AP, 2.8 mm from bregma; ML,
4.2 mm; DV, 7.8 mm relative to bregma). The coordinates
were adopted from the Paxinos and Watson rat atlas [23].
Two screw EEG electrodes were placed over the left
frontal and parietal lobes of cortices, and a third EEG elec-
trode was placed over the right cerebellum and served to
ground the animal to reduce signal artifacts. Rats in the
group 1 were implanted with 6 EEG electrodes; three elec-
trodes were implanted in the left frontal, parietal and
occipital lobes and the other three electrodes were
implanted in the coordinate right hemisphere. One add-
itional reference electrode was placed over the right
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routed to a Teflon pedestal (Plastics One, Roanoke, VA,
USA). The Teflon pedestal was then cemented to the
skull with dental acrylic (Tempron, GC Co., Tokyo,
Japan). The incision was treated topically with poly-
sporin (polymixin B sulfate – bacitracin zinc) and the
animals were allowed to recover for seven days prior to
the initiation of experiments. The rats were housed sep-
arately in individual recording cages in the isolated
room, in which the temperature was maintained at 23 ±
1°C and the light:dark (L:D) rhythm was controlled in a
12:12 h cycle (40 Watt × 4 tubes illumination). Food
(5001 rodent diet, LabDiet) and water were available ad
libitum. All procedures performed in this study were ap-
proved by the National Taiwan University Animal Care
and Use Committee.
Experimental protocol
On the 2nd postsurgical day, the rats were connected to
the recording apparatus (see below) via a flexible tether.
As such, the rats were allowed relatively unrestricted
movement within their own cages. One week after rats
had adapted to the 12:12-hour L:D cycle after surgery, a
24-hour undisturbed baseline EEG recordings were
obtained beginning at dark onset on the 1st recording
day in rats from all groups. Nine groups of rats were
used in the study as follows. Group 1 (n = 3) was used to
determine the focal epilepsy induced by administration
of pilocarpine into the left CeA. Rats in the group 2
(n = 6) received a 30-min 100 Hz EA stimulation of
bilateral Feng-Chi acupoints per day, beginning at 30 mi-
nutes before the dark period and performing in three
consecutive days (the EA group). EEGs were recorded
right after the end of the last period of EA stimuli and
lasted for 24 hours. Rats in the group 3 (n = 6) were ad-
ministered with pilocarpine into the left CeA and EEGs
were recorded beginning from the dark onset of the L:D
cycle (the pilocarpine group). In the group 4 (n = 6), rats
received the same EA stimulation protocol as those rats
in the group 2 and were respectively administered with
PFS and pilocarpine into the CeA before and after the
last period of EA stimulation (the PFS + EA + pilocarpine
group). Rats in the group 5 (n = 6) were used to deter-
mine the effects of opioid receptor antagonist, naloxone,
on the 100 Hz EA-induced alterations in the epilepti-
form EEGs (the naloxone + EA + pilocarpine group). Rats
in the group 6 (n = 6), 7 (n = 6), and 8 (n = 6) were
respectively used to depict the effects of μ-receptor
antagonist (naloxonazine, the naloxonazine + EA + pilo-
carpine group), δ-receptor antagonist (naltrindole, the
natrindole + EA + pilocarpine group) and κ-receptor
antagonist (nor-binaltorphimine, the nor-binaltorphimine +
EA + pilocarpine group) on the 100 Hz EA-induced
alterations of the epileptiform EEGs. Rats in groups 5-8received the similar protocol as those in the group
4, except that naloxone (10 μg/μl), naloxonazine
(10 μg/μl), naltrindole (10 μg/μl) and nor-binaltor-
phimine (10 μg/μl) were administered into the CeA
before the last period of EA stimulation in the group
5, 6, 7 and 8, respectively. Rats in the group 9
(n = 6) had the similar protocol as those in the group
4, except that rats received the sham EA stimulation
(the sham EA group). The schematic representation
of the experimental protocol was depicted in Figure 1.
When 100 Hz EA was given (see later), all rats were
lightly anesthetized with 29/4 mg/kg of ketamine/xyla-
zine (one third of the dose which we used for surgery
in our previous studies [9,10,22]), after which rat woke
up in 30 to 35 minutes. A 30-min period of EA
stimulation was administered before the onset of the
dark period per day and was applied in three consecu-
tive days. The anesthetization was given 30 minutes
prior to the dark period onset and lasted for 30 mi-
nutes. The 100 Hz EA stimulus was delivered via the
bilateral insertion of stainless needles (32 gauge × 1”,
Shanghai Yanglong Medical Articles Co.) on Feng-Chi
(GB20) acupoints in the depth of 2 mm. The stimulus
consisted of a train of biphasic pulses (150 μs dur-
ation each) of 100 Hz with intensity of 1 mA, and was
delivered by Functions Electrical Stimulator (Trio 300,
I.T.O., Japan). The location of Feng-Chi acupoints in
the rat is anatomically similar to that in human. The
acupoint of Feng-Chi (GB 20) locates in the depression
between the upper portion of m. sternocleidomastoi-
deus and m. trapezius in human. Sham EA was
performed by stimulation of a non-acupoint located at
the ventral conjunction between the forelimb and the
trunk as previous described [24].
Apparatus and recording
Signals from the EEG electrodes were fed into an ampli-
fier (Colbourn Instruments, Lehigh Valley, PA; model
V75-01). The EEG was amplified (factor of 5,000) and
analog bandpass was filtered between 0.1 and 40 Hz
(frequency response: ±3 dB; filter frequency roll off:
12 dB/octave). These conditioned EEG signals were sub-
jected to analog-to-digital conversion with 16-bit preci-
sion at a sampling rate of 128 Hz (NI PCI-6033E;
National Instruments, Austin, TX). The digitized EEG
waveforms were stored as binary computer files pending
subsequent analyses. Postacquisition determinations of
the onset and the duration of the EEG seizure occur-
rence were done by the visual scoring using AxoScope
10 Software (Molecular Devices, Sunnyvale, CA, USA).
We defined EEG documented seizures as the visualization
of epileptiform spikes with amplitudes of greater than








































Figure 1 Schematic representation of the experimental protocol. Closed bars indicate the dark period and open bars represent the light
period of the 12:12 h light:dark cycle. Arrows depict the time of microinjections. R: EEG recording; Pilo: pilocarpine; EA: electroacupuncture;
N: naloxone; μ-ant: μ-antagonist (naloxonazine); δ-ant: δ-antagonist (naltrindole); κ-ant: κ-antagonist (nor-binaltorphimine).
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All values acquired from the EEG recordings were pre-
sented as the mean ± SEM for the indicated sample sizes.
Unpaired student t-test for the duration of epileptiform
EEGs were performed to analyze and compare the differ-
ence between groups. An α level of p < 0.05 was taken as
indicating a statistically significant difference.
Results
Administration of pilocarpine into the left CeA induces
focal epilepsy
The predominant epileptiform EEGs were recorded from
the left parietal electrode and some epileptic activities
were also acquired from the left occipital electrode when
administration of pilocarpine (1 mg) into the CeA in rats
of group 1, whereas no epileptic activity was recorded
from the rest of four electrodes (Figure 2). The epileptic
EEGs were primarily recorded immediately after pilo-carpine injection (Figure 2B & Figure 3C), and the epi-
leptic recurrence occasionally happened during a day
(Figure 3C). The average of time exhibiting epileptiform
EEGs in the pilocarpine group (the group 3) was 23.9 ±
5.4% during the dark period and 20.2 ± 5.2% during the
following light period (Figure 4A & 4B). This observa-
tion indicates that administration of pilocarpine into the
left CeA successfully induces focal epilepsy in rats.
The effect of 100 Hz EA on pilocarpine-induced focal
epilepsy
We determined the effect of 100 Hz EA of bilateral
Feng-Chi acupoints on the epileptiform EEG activities
induced by pilocarpine. There was no epileptic activity
been recorded in the naïve rats without any manipula-
tion (Figures 3A, 3E & 4). We surprisingly found that
100 Hz EA of bilateral Feng-Chi acupoints induced
epileptiform EEGs in four out of six (4/6) naïve rats
Figure 2 The focal epilepsy induced by microinjection of pilocarpine into the CeA. Panels A, B, C, D, E and F represent the EEG signals
acquired from the electrodes of left frontal, left parietal, left occipital, right frontal, right parietal and right occipital cortices, respectively. The
epileptiform EEGs were predominantly recorded from the electrode of left parietal cortex.
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tiform EEGs during the 12 hours of the dark period in
the EA group (the group 2) was 2.3 ± 1.0%, whereas no
epileptiform activity was observed in the following light
period (Figure 4A & 4B). The predominant epileptiform
EEGs induced by 100 Hz EA were observed during the
first two hours after the EA stimulation (Figure 4C). Fur-
thermore, the high-frequency EA stimulation aggravated
the amplitude and duration of the epileptic EEG activity
induced by pilocarpine (Figures 3D, 3H & 4). The aver-
age of time presenting epileptic activities in the PFS +
EA + pilocarpine group (the group 4) was significantly
enhanced to 51.2 ± 6.1% during the dark period (p <
0.01, when compared to the values obtained from the
pilocarpine group) and increased to 57.5 ± 6.1% during
the following light period (p < 0.01, when compared to
the results acquired from the pilocarpine group;
Figure 4A, 4B & 4C). Our previous results have shown
that sham EA stimulation did not alter baseline EEGs
[9,10]. We also observed that sham EA stimulation did
not exhibit effect on pilocarpine-induced epileptiform
EEGs (data not shown).
CeA opioid receptors mediate EA-induced augmentation
of focal epilepsy
Application of naloxone (10 μg) significantly reduced the
amplitude and duration of EA-induced augmentation of
epileptic EEGs (Figure 5B & 5G). The average of time
exhibiting epileptic EEGs in the naloxone + EA + pilocar-
pine group was significantly reduced to 19.7 ± 3.5% dur-
ing the dark period (p < 0.01, when compared to the
values obtained from the PFS + EA + pilocarpine group;Figure 6A) and decreased to 5.0 ± 1.1% during the
following light period (p < 0.01, when compared to the
data acquired from the PFS + EA + pilocarpine group;
Figure 6B). Both naloxonazine (10 μg) and naltrindole
(10 μg) exhibited similar effect in reducing the ampli-
tude and duration of EA-induced augmentation of
epileptic EEGs (Figures 5 & 6). The average of time pre-
senting epileptic EEGs in the naloxonazine + EA + pilo-
carpine group and in the naltrindole + EA + pilocarpine
group was respectively decreased to 18.2 ± 3.8% (p <
0.01) and 1.9 ± 1.1% (p < 0.01, when compared to the
values obtained from the PFS + EA + pilocarpine group)
during the dark period, and it was decreased to 3.3 ±
1.3% (p < 0.01) and 0% (p < 0.01, when compared to the
data acquired from the PFS + EA + pilocarpine group)
during the following light period (Figure 6). Nor-binal-
torphimine (10 μg) reduced the duration of EA-induced
augmentation of epileptic activity, but it exhibited less
effect in suppressing the amplitude of epileptiform EEGs
(Figure 5E & 5J). The average of time exhibiting epileptic
EEGs in the nor-binaltorphimine + EA + pilocarpine group
was significantly reduced to 30.5 ± 4.7% during the dark
period (p < 0.01, when compared to the values obtained
from the PFS + EA+ pilocarpine group) and decreased to
23.7 ± 4.0% during the following light period (p < 0.01,
when compare to the results acquired from the PFS + EA +
pilocarpine group; Figure 6).
Discussion
The goal of this study is to elucidate the effect of EA
stimulation of Feng-Chi acupoints on epileptic suppres-
sion. Epilepsy can be divided into focal and generalized
Figure 3 The effect of 100 Hz EA stimulation of bilateral Feng-Chi acupoints on the epileptic activities. Panels A, B, C and D respectively
depict the EEG signals recorded from the naïve rats, the EA group, the pilocarpine group, and the PFS + EA + pilocarpine group, beginning from
the dark onset of the dark period. Red lines indicate the time for pilocarpine administration (at the end of the 30-min EA stimulation). The blue
boxes represent the epileptiform EEGs. Green arrowheads were the artifacts. The larger amplitudes, with EEG signals less than 2 mV, appeared in
panels A, B and C were delta waves, which represent the state of slow wave sleep. Panels E, F, G and H were the enlarged figures which were
respectively expanded the time scale from the panels A, B, C and D, and were recorded from the beginning of the dark period.
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national League Against Epilepsy (ILAE). Focal epilepsy
is usually subtle and the epileptiform activity starts in
one area of brain and may spread to other brain regions.
In contrast, generalized epilepsy, which is more severe
than focal epilepsy, is result of abnormal brain activity in
both hemispheres. In this study, we would like to first
determine whether EA of Feng-Chi acupoints suppresses
focal epilepsy. Systemic administration of pilocarpine in
rats leads to a pattern of generalized seizure and status
epilepticus [25]. However, the reliability of focal epilepsy
induced by administration of pilocarpine into CeA has
been confirmed in this study (Figure 2). We found that
epileptiform EEGs were primarily recorded from the left
parietal electrode near left CeA, but were not acquired
from electrodes implanted on the right hemisphere,when EEG signals were acquired by multiple electrodes
on both hemispheres.
Acupuncture and EA has been recommended as an al-
ternative medicine for several therapeutic indications by
the World Health Organization (WHO), such as allevi-
ation of pain, reduction of inflammation and manage-
ment of insomnia. The clinical therapeutic effects and
the underlying mechanisms of EA in pain relief has been
well elucidated; however, its effects in other aspects,
such as neurodegenerative diseases, insomnia and epi-
lepsy, has been less investigated. Feng-Chi acupoint (GB
20), located in the depression between the upper portion
of m. sternocleidomastoideus and m. trapezius in human,
has been documented in the Lingshu Jing (the Classic of
the Miraculous Pivot) and indicated the therapeutic effects




Figure 4 The summary of 100 Hz EA stimulation of bilateral Feng-Chi acupoints on the epileptic activities. Panel A depicts the results
obtained from the dark period and panel B demonstrates the data acquired from the light period. The bars from the left to the right in both
panels A and B represent the results obtained from the naïve rats, the EA group, the pilocarpine group, and the PFS + EA + pilocarpine group. In
panel C, the black circles represent the values obtained from the naïve group, the black triangles depict the results of the EA group, the white
circles demonstrate the values obtained from the pilocarpine group, and the white triangles indicate the data acquired from the PFS + EA +
pilocarpine group. #: p < 0.05 vs. the naïve rats; ##: p < 0.01 vs. the naïve rats; **: p < 0.01 vs. the pilocarpine group.
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patients with refractory epilepsy who do not respond to
the current AEDs. However, the effect of acupuncture in
treating epilepsy is controversial. Activation of vagus
nerve by EA has been reported as a promising neuropro-
tective therapy for patients with refractory epilepsy [7,8].
However, bilateral acupuncture of Taichon (LR3), Hegu
(LI4) and Baihui (GV20) acupoints did not significantly
alter the frequency of seizure occurrence in patients with
refractory epilepsy, indicating that acupuncture is not
beneficial in patients with refractory epilepsy [26]. A
Cochrane review also concludes that no enough scientific
evidence supports the effectiveness of acupuncture in epi-
lepsy therapy [27]. To clarify the dispute of acupuncture
effect in the epilepsy therapy, we designed this current
study to determine the effect of high frequency (100 Hz)
EA of bilateral Feng-Chi acupoints in the focal epilepsy in-
duced by administration of pilocarpine into the left CeA.Our results indicated that administration of pilocarpine
into the left CeA induced focal epilepsy, however, the
pilocarpine-induced epileptiform EEGs were augmented
when rats previously received the 100 Hz EA stimuli of
Feng-Chi acupoints. This result indicated that high-
frequency (100 Hz) EA stimulation of bilateral Feng-Chi
acupoints exacerbated pilocarpine-induced epileptic ac-
tivity, rather than protecting against epilepsy. In fact,
our data demonstrated that 100 Hz EA stimulation of
bilateral Feng-Chi acupoints induced epileptic activities
in the naïve rats, which did not receive any manipula-
tion. The characteristic of epileptogenesis induced by
the high-frequency EA stimulation of bilateral Feng-Chi
acupoints per se may cause the aggravation of pilocarpine-
induced epileptiform EEG activities. These observations,
since they subvert the functions of Feng-Chi acupoints
documented in the Lingshu Jing, surprise us. The possible
reasons of contradiction between our findings and the
Figure 5 The effects of naloxone, naloxonazine, naltrindole and nor-binaltorphimine on the 100 Hz EA-induced exacerbation of
epileptic activities. Panels A, B, C, D and E respectively depict the EEG signals recorded from the PFS + EA + pilocarpine group, naloxone + EA +
pilocarpine group, the naloxonazine + EA + pilocarpine group, the naltrindole + EA + pilocarpine group, and the nor-binaltorphimine + EA +
pilocarpine group, beginning from the dark onset of the dark period. Red lines indicate the time for pilocarpine administration (at the end of the
30-min EA stimulation). The blue boxes represent the epileptiform EEGs. Green arrowheads were the artifacts. The larger amplitudes, with EEG
signals less than 2 mV, appeared in panels B, C and D were delta waves, which represent the state of slow wave sleep. Panels F, G, H, I and J
were the enlarged figures which were respectively expanded the time scale from the panels A, B, C, D and E, and were recorded from the
beginning of the dark period.
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or without delivering electrical currents into Feng-Chi
acupoints is a fact. The effect of epileptic suppression doc-
umented in Lingshu Jing is manipulated by dry needling,
whereas the exacerbation of epilepsy we observed in this
study was the results after EA with delivering currents
into acupoints. Second, different stimulation frequenciesmay differ the outcomes. It is worthy to investigate the
effect of different EA stimulation frequencies, especially
for the lower frequency (e.g., 10 Hz), on the epileptic
activity.
The theory underlying EA is still controversial, although
the action of EA has been widely discussed in literature.




Figure 6 The summary for the effects of naloxone, naloxonazine, naltrindole and nor-binaltorphimine on the 100 Hz EA-induced
exacerbation of epileptic activities. Panel A depicts the results obtained from the dark period and panel B demonstrates the data acquired
from the light period. The bars from the left to the right in both panels A and B represent the results obtained from the PFS + EA + pilocarpine
group, naloxone + EA + pilocarpine group, naloxonazine + EA + pilocarpine group, naltrindole + EA + pilocarpine group and nor-binaltorphimine +
EA + pilocarpine group. In panel C, the black circles represent the values obtained from the PFS + EA + pilocarpine group, the black triangles
depict the results of the naloxone + EA + pilocarpine group, the white circles demonstrate the values obtained from the naloxonazine + EA +
pilocarpine group, the white diamonds elucidate the results of the naltrindole + EA + pilocarpine group, and the white triangles indicate the data
acquired from the nor-binaltorphimine + EA + pilocarpine group. **: p < 0.01 vs. the PFS + EA + pilocarpine group.
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since 1970’s enhances the investigation of underlying
mechanisms of EA, especially in the EA-induced analgesia.
Three main receptor subtypes of the opioid receptors, in-
cluding the μ-, δ- and κ-opioid receptors, in the spinal cord
involve in the mechanisms of EA-induced analgesia.
Endormorphin and dynorphin are respectively considered
as the relatively pure μ- and κ-opioid receptor agonists
[28,29], while enkephalin and β-endorphin are mixed μ-
and δ- opioid receptor agonists (review [30,31]). Han and
his colleagues have revealed that low frequency (2 Hz) EA
increases met-enkephalin, but not dynorphin, in the spinal
cord; while high frequency (100 HZ) EA increases the re-
lease of dynorphin rather than that of met-enkephalin [19].
The stimulation of EA between low and high frequency
(e.g. 15 Hz) activates both enkephalins and dynorphins
[19]. They further demonstrated that the analgesic effect
induced by low-frequency EA stimulation is mediatedby μ- and/or δ-opioid receptors; in contrast, high-
frequency EA-induced analgesia is mediated by κ-opioid
receptors [17,18]. These observations suggest that different
endogenous opioid peptides would be released and act on
distinct opioid receptors in the spinal cord under different
stimulating conditions of EA. It remains unclear whether
the endogenous opioid peptides and their receptors in the
central nervous system (CNS) play a role in the epilepto-
genesis or they possess the anticonvulsant effect. Several
studies indicate that opioid peptides inhibit the epileptic
activity. For example, low doses of morphine or opioid
peptides exhibit an anticonvulsant effect, which is blocked
by low doses of naloxone [32]. Intracerebroventricular
(ICV) administration of dynorphin suppresses the electro-
convulsive shock- and kindled-induced seizure [33,34].
Temporal lobe epilepsy increases opioid receptors in the
temporal neocortex in humans [35], which may mediate
the anticonvulsant effects to limit the spread of electrical
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thermore, evidence that the prodynorphin knockout mice
display a significantly reduced seizure threshold as assessed
by administration of pentylenetetrazole suggests the anti-
convulsant effect of endogenous opiates [37]. However,
bulks of studies indicate that endogenous opioid peptides
and their receptors contribute to the epileptogenesis. ICV
injections of morphine and opioid peptides evoke patho-
logical epileptiform EEGs [32,38-42]. β-endorphin could
induce nonconvulsive limbic epileptiform activity in rats
when the dose is devoid of analgesic and other behavioral
signs [42]. Enkephalin and β-endorphin administered
intracerebroventricularly or microinjected into discrete
subcortical areas produce epileptic activities [32].
Repeated injection of small amounts of β-endorphin or
met-enkephalin into the hippocampus or amygdala
develops kindled generalized convulsions [39,40]. Dynor-
phin inhibits GABAergic neurons by activation of μ- and
κ-opioid receptors, which results in the decrease of GABA
release and facilitates seizure [38]. As for the opioid recep-
tors, Carter et al. have demonstrated that opioid receptors
are involved in the pathogenesis of a wide spectrum of
seizure disorders [43]. Based on aforementioned evidence
and our result of exacerbating pilocarpine-induced epilep-
tiform activities by EA stimulation of Feng-Chi acupoints,
we hypothesized that the EA-augmented epileptic activity
is mediated by activation of opioid receptors in the CeA.
Our results indicated that application of naloxone
(a broad spectrum of opioid receptor antagonist), naloxo-
nazine (a μ-receptor antagonist), naltrindole (a δ-receptor
antagonist) or nor-binaltorphimine (a κ-receptor antagon-
ist) significantly suppressed both the amplitude and the
duration of EA-induced augmentation of epileptiform
activity. The order of efficacy in suppressing EA-induced
epileptiform EEGs was naltrindole > naloxone ≅ naloxona-
zine > nor-binaltorphimine. Activation of opioid receptors
may mediate the EA-induced epileptic activities in the
naïve rats; however, this needs to be further confirmed in
the future study. Nevertheless, our current results favor
the role of CeA opioid receptors in the epileptogenesis.
Han and his colleagues demonstrate that the analgesic ef-
fects produced by low-frequency EA stimuli and high-
frequency EA stimuli are mediated by different opioid
receptors [17,30]. Our previous study also elicited that dis-
tinct opioid receptors in the NTS involve in different
stimulation frequencies of EA-induced sleep enhancement
[9,10], which is similar to the underlying mechanisms of
EA-induced analgesia in the spinal cord as reported by
Han and his colleagues. However, our current results indi-
cate that 100 Hz EA stimulation of bilateral Feng-Chi acu-
points activated μ-, δ- and κ-opioid receptors in the CeA
to exacerbate pilocarpine-induced epilepsy. It is worthy
to further investigate the effect of low-frequency (e.g.,
10 Hz) EA stimulation of bilateral Feng-Chi acupointson pilocarpine-induced epileptiform activity and the in-
volvement of opioid receptors in the CeA. Strategy by
employing pharmacological blockade to elucidate the
involvement of particular opioid receptors in 100 Hz
EA-induced augmentation of epileptiform activity is
appropriate. However, it would be of interest to mimic
the EA-induced epileptiform EEGs by microinjection of
opioid-receptor agonists, e.g. β-endorphin, encephalin
and dynorphin, into the CeA in future.
Conclusion
In summary, our current results indicated that high-
frequency (100 Hz) EA stimulation of bilateral Feng-Chi
acupoints exacerbated pilocarpine-induced focal epi-
lepsy. The EA-induced exacerbation of focal epilepsy
was blocked by administration of μ-, δ-, or κ-opioid
receptor antagonist into the CeA, demonstrating the in-
volvement of CeA opioid receptors. Our current results
suggest that 100 Hz EA stimulation of bilateral Feng-
Chi acupoints did not exhibit effect to against epilepsy,
whereas it further deteriorated the focal epilepsy.
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